Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative Colitis

Clinical trial NCT03029143 · COMPLETED

Trial details

NCT number: NCT03029143
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Colitis, Ulcerative

Start date: 2017-03-29
Primary completion: 2020-10-16
Enrollment: 278

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.